190 related articles for article (PubMed ID: 32722958)
1. Access to HIV Viral Load Testing and Antiretroviral Therapy Switch Practices: A Multicountry Prospective Cohort Study in Sub-Saharan Africa.
Ondoa P; Kim AA; Boender TS; Zhang G; Kroeze S; Wiener J; Rinke de Wit T; Nkengasong J;
AIDS Res Hum Retroviruses; 2020 Nov; 36(11):918-926. PubMed ID: 32722958
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
[TBL] [Abstract][Full Text] [Related]
4. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa.
Sigaloff KC; Hamers RL; Wallis CL; Kityo C; Siwale M; Ive P; Botes ME; Mandaliya K; Wellington M; Osibogun A; Stevens WS; van Vugt M; de Wit TF;
J Acquir Immune Defic Syndr; 2011 Sep; 58(1):23-31. PubMed ID: 21694603
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC
J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546
[TBL] [Abstract][Full Text] [Related]
6. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland.
Etoori D; Ciglenecki I; Ndlangamandla M; Edwards CG; Jobanputra K; Pasipamire M; Maphalala G; Yang C; Zabsonre I; Kabore SM; Goiri J; Teck R; Kerschberger B
J Int AIDS Soc; 2018 Oct; 21(10):e25194. PubMed ID: 30350392
[TBL] [Abstract][Full Text] [Related]
7. The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.
Glass TR; Motaboli L; Nsakala B; Lerotholi M; Vanobberghen F; Amstutz A; Lejone TI; Muhairwe J; Klimkait T; Labhardt ND
PLoS One; 2019; 14(8):e0220337. PubMed ID: 31461455
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R;
Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603
[TBL] [Abstract][Full Text] [Related]
9. Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome.
Johnston V; Fielding K; Charalambous S; Mampho M; Churchyard G; Phillips A; Grant AD
PLoS One; 2012; 7(5):e36997. PubMed ID: 22666338
[TBL] [Abstract][Full Text] [Related]
10. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
[TBL] [Abstract][Full Text] [Related]
12. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of near point-of-care viral load implementation in public health facilities across seven countries in sub-Saharan Africa.
Boeke CE; Joseph J; Atem C; Banda C; Coulibaly KD; Doi N; Gunda A; Kandulu J; Kiernan B; Kingwara L; Maokola W; Maparo T; Mbaye RN; Mtumbuka E; Mziray J; Ngugi C; Nkakulu J; Nzuobontane D; Okomo Assoumo MC; Peter T; Rioja MR; Sacks JA; Simbi R; Vojnov L; Khan SA
J Int AIDS Soc; 2021 Jan; 24(1):e25663. PubMed ID: 33455081
[TBL] [Abstract][Full Text] [Related]
14. Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.
Johnston V; Fielding KL; Charalambous S; Churchyard G; Phillips A; Grant AD
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):370-80. PubMed ID: 22820803
[TBL] [Abstract][Full Text] [Related]
15. Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010-2017.
Wang Y; Barnhart S; Francois K; Robin E; Kalou M; Perrin G; Hall L; Koama JB; Marinho E; Balan JG; Honoré JG; Puttkammer N
BMC Infect Dis; 2020 Apr; 20(1):283. PubMed ID: 32299389
[TBL] [Abstract][Full Text] [Related]
16. Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
Eholie SP; Moh R; Benalycherif A; Gabillard D; Ello F; Messou E; Zoungrana J; Diallo I; Diallo M; Bado G; Cisse M; Maiga AI; Anzian A; Toni TD; Congo-Ouedraogo M; Toure-Kane C; Seydi M; Minta DK; Sawadogo A; Sangaré L; Drabo J; Karcher S; Le Carrou J; de Monteynard LA; Peytavin G; Gabassi A; Girard PM; Chaix ML; Anglaret X; Landman R;
Lancet HIV; 2019 Nov; 6(11):e750-e759. PubMed ID: 31601544
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy: An observational cohort study.
Cao P; Su B; Wu J; Wang Z; Yan J; Song C; Ruan Y; Xing H; Shao Y; Liao L
Medicine (Baltimore); 2018 Jul; 97(28):e11463. PubMed ID: 29995803
[TBL] [Abstract][Full Text] [Related]
18. Optimised electronic patient records to improve clinical monitoring of HIV-positive patients in rural South Africa (MONART trial): study protocol for a cluster-randomised trial.
Iwuji C; Osler M; Mazibuko L; Hounsome N; Ngwenya N; Chimukuche RS; Khoza T; Gareta D; Sunpath H; Boulle A; Herbst K
BMC Infect Dis; 2021 Dec; 21(1):1266. PubMed ID: 34930182
[TBL] [Abstract][Full Text] [Related]
19. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
Schoffelen AF; Wensing AM; Tempelman HA; Geelen SP; Hoepelman AI; Barth RE
PLoS One; 2013; 8(3):e58526. PubMed ID: 23505529
[TBL] [Abstract][Full Text] [Related]
20. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
